151 results
Page 4 of 8
8-K
EX-99.1
xs27a10 i9bz23
10 Feb 21
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2029
5:29pm
8-K
EX-99.1
5e5dw8lpvtx61ovl82
10 Feb 21
Catalent Announces Launch of Private Offering of $475 Million of Senior Unsecured Notes Due 2029
7:50am
8-K
tt855vjlw20ii48gjh4
10 Feb 21
Catalent Announces Launch of Private Offering of $475 Million of Senior Unsecured Notes Due 2029
7:50am
8-K
EX-99.1
trg760kn csvd
2 Feb 21
Catalent, Inc. Reports Second Quarter Fiscal 2021 Results
7:21am
8-K
EX-99.1
l4216tgfz8033hpjc6an
3 Nov 20
Catalent, Inc. Reports First Quarter Fiscal 2021 Results
7:13am
8-K
EX-99.1
f8rjvubd 06
31 Aug 20
Catalent, Inc. Reports Fourth Quarter Fiscal 2020 Results
7:06am
8-K
EX-99.1
his6kfxr
30 Jul 20
Results of Operations and Financial Condition
8:22am
424B5
a2mng9wdsq wk
12 Jun 20
Prospectus supplement for primary offering
4:16pm
8-K
EX-99.1
e5zr73qn62c29h
11 Jun 20
Catalent, Inc. Announces Pricing of Public Offering of Common Stock
8:52am
8-K
EX-99.1
rk8je
10 Jun 20
Catalent, Inc. Announces Public Offering of Common Stock
4:19pm
424B5
t2j04ad4
10 Jun 20
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
azbvnzz36f 3x
5 May 20
Catalent, Inc. Reports Third Quarter Fiscal 2020 Results
7:32am
8-K
EX-99.1
i0lcxuyni
30 Apr 20
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
4:43pm
8-K
EX-99.1
sybx870 q45t
20 Feb 20
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028
4:28pm
8-K
q25mo
19 Feb 20
Catalent Announces Launch of Private Offering of €450 Million of Senior Unsecured Notes Due 2028
6:08am
8-K
EX-99.1
7v3p2iu5uzy6mo
19 Feb 20
Catalent Announces Launch of Private Offering of €450 Million of Senior Unsecured Notes Due 2028
6:08am
8-K
EX-99.1
hp66i3u
4 Feb 20
Catalent, Inc. Announces Pricing of Public Offering of Common Stock
12:00am